Edition:
India

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,473.60INR
19 Jan 2018
Change (% chg)

Rs0.35 (+0.01%)
Prev Close
Rs2,473.25
Open
Rs2,477.90
Day's High
Rs2,489.00
Day's Low
Rs2,455.00
Volume
15,802
Avg. Vol
11,097
52-wk High
Rs2,798.50
52-wk Low
Rs2,201.20

Revenue & Earnings Per Share

 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 10,413.00 10,413.00 10,413.00 --
Year Ending Mar-18 8 31,688.30 33,893.00 29,680.00 34,873.60
Year Ending Mar-19 8 35,770.90 39,101.00 33,240.00 37,297.80
Earnings (per share)
Year Ending Mar-18 8 42.57 46.00 37.49 65.10
Year Ending Mar-19 8 52.83 63.40 40.29 54.62
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 62.45 31.10 32.90
P/E High - Last 5 Yrs. -- 40.98 46.03
P/E Low - Last 5 Yrs. -- 23.80 24.39
Beta 0.17 0.90 0.89
Price to Sales (TTM) 14.01 3.98 5.45
Price to Book (MRQ) -- 4.82 5.38
Price to Tangible Book (MRQ) -- 5.57 6.89
Price to Cash Flow (TTM) 174.34 23.02 23.43
% Owned Institutions -- 1.23 2.16

Dividends

  Company industry sector
Dividend Yield 1.24 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) 0.00 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.69 5.44
Sales - 5 Yr. Growth Rate -- 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) -- 2.88 2.97
LT Debt to Equity (MRQ) -- 9.81 12.10
Total Debt to Equity (MRQ) -- 13.80 16.38
Interest Coverage (TTM) -- 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 55.13 54.76
Gross Margin - 5 Yr. Avg. -- 52.41 52.45
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 18.54 15.33
Operating Margin (TTM) 33.89 14.40 7.60
Operating Margin - 5 Yr. Avg. -- 14.46 10.79
Pre-Tax Margin (TTM) 33.89 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. -- 14.77 11.19
Net Profit Margin (TTM) 23.12 11.09 4.70
Net Profit Margin - 5 Yr. Avg. -- 11.11 7.50
Effective Tax Rate (TTM) 31.77 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. -- 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 948,195,516 855,725,045
Net Income/Employee (TTM) 718,922 111,561,295 100,665,187
Receivable Turnover (TTM) -- 5.61 5.76
Inventory Turnover (TTM) -- 2.57 3.34
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.41 10.97
Return on Assets - 5 Yr. Avg. -- 12.98 12.39
Return on Investment (TTM) -- 14.84 14.40
Return on Investment - 5 Yr. Avg. -- 16.97 16.20
Return on Equity (TTM) -- 16.32 16.09
Return on Equity - 5 Yr. Avg. -- 18.05 17.53
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -2.64 99 25
13 Week -6.52 -7.86 99 36
26 Week -11.71 -17.56 99 31
52 Week -17.27 -26.91 99 12
YTD -11.53 -25.96 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.36%
# of Holders: 21
Total Shares Held: 9,622,236
3 Mo. Net Change: 100,635
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 4
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.